126 related articles for article (PubMed ID: 27173352)
1. Functional polymorphisms of the cyclooxygenase-2 gene and prognosis of hepatocellular carcinoma - a cohort study in Chinese people.
Liang R; Yan XX; Lin Y; Li Q; Yuan CL; Liu ZH; Li YQ
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173352
[TBL] [Abstract][Full Text] [Related]
2. Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ülger Y
Mol Cell Biochem; 2011 Jan; 347(1-2):201-8. PubMed ID: 21042835
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
[TBL] [Abstract][Full Text] [Related]
4. The association between three cyclooxygenase-2 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
Chen Z; Zhu J; Huang C; Lian F; Wu G; Zhao Y
PLoS One; 2015; 10(3):e0118251. PubMed ID: 25730260
[TBL] [Abstract][Full Text] [Related]
5. COX-2 polymorphisms -765G→C and -1195A→G and hepatocellular carcinoma risk.
Gharib AF; Karam RA; Abd El Rahman TM; Elsawy WH
Gene; 2014 Jun; 543(2):234-6. PubMed ID: 24720952
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients.
Qu K; Liu SS; Wang ZX; Huang ZC; Liu SN; Chang HL; Xu XS; Lin T; Dong YF; Liu C
World J Gastroenterol; 2015 Apr; 21(14):4310-22. PubMed ID: 25892883
[TBL] [Abstract][Full Text] [Related]
7. Association of VEGFA polymorphisms with susceptibility and clinical outcome of hepatocellular carcinoma in a Chinese Han population.
Liu F; Luo L; Wei Y; Wang W; Wen T; Yang J; Xu M; Li B
Oncotarget; 2017 Mar; 8(10):16488-16497. PubMed ID: 28147320
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
9. Caspase polymorphisms and prognosis of hepatocellular carcinoma.
Zhang S; Xiao Q; Shi Z; Yu G; Ma XP; Chen H; Zhang P; Shen S; Sai-Yin HG; Chen TY; Lu PX; Wang NJ; Ren W; Huang P; Xie J; Conran C; Zheng SL; Yu L; Xu J; Jiang DK
PLoS One; 2017; 12(4):e0176802. PubMed ID: 28453560
[TBL] [Abstract][Full Text] [Related]
10. Fas -670 A/G polymorphism predicts prognosis of hepatocellular carcinoma after curative resection in Chinese Han population.
Guo XY; Xia YL; Li ZY; Li R; Fan Y; Yao WM; Liu F
Hepatobiliary Pancreat Dis Int; 2022 Feb; 21(1):33-40. PubMed ID: 34366198
[TBL] [Abstract][Full Text] [Related]
11. Association of Functional Genetic Variants of HOTAIR with Hepatocellular Carcinoma (HCC) Susceptibility in a Chinese Population.
Li H; Tang XM; Liu Y; Li W; Chen Q; Pan Y
Cell Physiol Biochem; 2017; 44(2):447-454. PubMed ID: 29141248
[TBL] [Abstract][Full Text] [Related]
12. Association between the c.1564A>T genetic polymorphism of the MDR1 gene and hepatocellular carcinoma in Chinese population.
Wan YY; Wang XW; Hui HX; Wan L
Genet Mol Res; 2014 Aug; 13(3):6820-6. PubMed ID: 25177961
[TBL] [Abstract][Full Text] [Related]
13. Associations between single nucleotide polymorphisms in RYBP and the prognosis of hepatocellular carcinoma in a Chinese population.
Zhu X; Wang Z; Qiu X; Tan C; Yu H; Bei C; Qin L; Ren Y; Tan S
Carcinogenesis; 2017 May; 38(5):532-540. PubMed ID: 28369212
[TBL] [Abstract][Full Text] [Related]
14. Association between COX-2 gene polymorphisms and risk of hepatocellular carcinoma development: a meta-analysis.
Lu SC; Zhong JH; Tan JT; Tang HL; Liu XG; Xiang BD; Li LQ; Peng T
BMJ Open; 2015 Oct; 5(10):e008263. PubMed ID: 26438136
[TBL] [Abstract][Full Text] [Related]
15. Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
Jiang Z; Jiang Q; Fang X; Wang P; Que W; Li H; Yu Y; Liu X; Wang C; Zhong L
BMC Cancer; 2021 May; 21(1):521. PubMed ID: 33964921
[TBL] [Abstract][Full Text] [Related]
16. Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population.
Bi J; Zhong C; Li K; Chu H; Wang B
Biomed Res Int; 2013; 2013():138785. PubMed ID: 23984316
[TBL] [Abstract][Full Text] [Related]
17. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.
Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S
Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200
[TBL] [Abstract][Full Text] [Related]
18. Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population.
Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J
Med Oncol; 2014 Dec; 31(12):301. PubMed ID: 25367853
[TBL] [Abstract][Full Text] [Related]
19. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
Yuan P; Wang S; Zhou F; Wan S; Yang Y; Huang X; Zhang Z; Zhu Y; Zhang H; Xing J
Cancer Sci; 2014 Jul; 105(7):825-32. PubMed ID: 24754267
[TBL] [Abstract][Full Text] [Related]
20. IL-17 and IL-21 polymorphisms in relation to HBV related hepatocellular carcinoma in Chinese Han population.
Wu W; Zeng Y; Lin J; Chen T; Xun Z; Li B; Wang C; Qin X; Qiu Y; Li Y; Chen M; Liang H; Li L; Shang H; Liu C; Ou Q
Infect Genet Evol; 2021 Jan; 87():104638. PubMed ID: 33232805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
